NL-OMON54425招募中4 期
Administration of immune checkpoint inhibitors through an elastomeric pump. A patient preference study and cost analysis. - Connect&Go
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >=18 years;
- •- Able and willing to give written informed consent;
- •- Planned treatment with nivolumab or pembrolizumab monotherapy (subjects
- •treated with nivolumab/ipilimumab combination treatment can participate in the
- •trial on days during which they receive nivolumab monotherapy) or any other EMA
- •approved ICI as monotherapy for any EMA approved indication and with any dose;
- •- Adequate Dutch language proficiency (at least proficiency level C1)
- •- At least 2 prior cycles of Nivolumab or Pembrolizumab therapy
- •- At least 4 remaining cycles of Nivolumab or Pembrolizumab monotherapy after
- •inclusion in the study.
排除标准
- •Prior infusion related reactions to Nivolumab or Pembrolizumab (any grade).
研究者
相似试验
尚未招募
不适用
Administration of immune checkpoint inhibitors through an elastomeric pump. A patient preference study and cost analysis.Solid tumors for which nivolumab or pembrolizumab monotherapy has an EMA approved indication. This includes (but is not limited to) melanoma, renal-cell cancer, NSCLC and head and neck cancer.NL-OMON25676Erasmus MC390
进行中（未招募）
1 期
Patient preference for administration of cancer immunotherapy via an elastomeric pump. A patient preference study and an economic analysis.Solid tumors for which nivolumab or pembrolizumab monotherapy is an EMA approved indication. This includes (but is not limited to) melanoma, renal-cell cancer, NSCLC and head and neck cancer.EUCTR2021-000058-24-NLErasmus MC Cancer Institute390
尚未招募
Unknown
Immune checkpoint inhibitor therapy for advanced, recurrent or metastatic non-small cell lung cancer with low or negative PD-L1 expression.JPRN-UMIN000050723Kobe University200
已完成
不适用
Combination therapy of immuno checkpoint inhibitors and radiosensitization treatment for metastatic melanomaJPRN-UMIN000026925Kochi University, Kochi Medical School5
进行中（未招募）
1 期
Pre-operative immunotherapy in early-stage colon cancersEUCTR2016-002940-17-NLAntoni van Leeuwenhoek155